An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Open Ventral Hernia Repair, Abdominoplasty, Open Abdominal Hysterectomy, Laparoscopic-assisted Colectomy, and Reduction Mammoplasty
Latest Information Update: 16 Feb 2023
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Adverse reactions; Registrational
- Sponsors Innocoll
- 10 Feb 2023 Status changed from recruiting to completed.
- 29 Aug 2022 Planned End Date changed from 28 Jul 2022 to 28 Jan 2023.
- 29 Aug 2022 Planned primary completion date changed from 28 Jul 2022 to 28 Jan 2023.